DANIEL EFIOM-EKAHA, MD
Hematology & Oncology Physician · YORK, PA
Individual Active NPI 1396783122
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 745 | 138,135 | $5,632,244 | $3,718,199 | $2,965,064 |
| 2023 | 778 | 130,332 | $4,634,653 | $2,688,539 | $2,139,084 |
| 2022 | 798 | 125,013 | $4,069,605 | $2,438,545 | $1,946,020 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22,445 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,200 | $46 | $37 |
| J9299 | Injection, nivolumab, 1 mg | 12,360 | $31 | $25 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,160 | $48 | $38 |
| J9025 | Injection, azacitidine, 1 mg | 10,037 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 8,220 | $26 | $21 |
| J1453 | Injection, fosaprepitant, 1 mg | 2,850 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,300 | $20 | $16 |
| J9267 | Injection, paclitaxel, 1 mg | 2,019 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,820 | $2 | $1 |
| 36415 | Insertion of needle into vein for collection of blood sample | 1,334 | $9 | $9 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,258 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | MD429211 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Pennsylvania
- NPI 1750380036
- NPI 1134324536
- NPI 1942209234
- NPI 1346635679
- NPI 1679749121
- NPI 1538663208
- NPI 1124311956
- NPI 1285991638
See all Hematology & Oncology Physician providers in Pennsylvania →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.